Search the Appendices of Resolution CM/Res(2018)1
2360 found
INN | ATC Code | Country | Classification | Last update | MA Number ▲ | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
AVACOPAN | L04AJ05 | IT | I | 28-04-2022 | EMEA/H/C/005523 | 11-01-2022 | VALID | |
MITAPIVAT | B06AX04 | IT | I | 18-08-2023 | EMEA/H/C/005540 | 09-11-2022 | VALID | |
ARTESUNATE | P01BE03 | IT | I | 28-04-2022 | EMEA/H/C/005550 | 22-11-2021 | VALID | |
PEGCETACOPLAN | L04AJ03 | IT | I | 28-04-2022 | EMEA/H/C/005553 | 13-12-2021 | VALID | |
TEZEPELUMAB | R03DX11 | IT | I | 18-11-2022 | EMEA/H/C/005588 | 19-09-2022 | VALID | |
ASCIMINIB | L01EA06 | IT | I | 18-11-2022 | EMEA/H/C/005605 | 25-08-2022 | VALID | |
DIFELIKEFALIN | V03AX04 | IT | I | 18-11-2022 | EMEA/H/C/005612 | 25-04-2022 | VALID | |
RIPRETINIB | L01EX19 | IT | I | 28-04-2022 | EMEA/H/C/005614 | 18-11-2021 | VALID | |
PEGUNIGALSIDASE ALFA | A16AB20 | IT | I | 14-11-2023 | EMEA/H/C/005618 | 04-05-2023 | VALID | |
FUTIBATINIB | L01EN04 | IT | I | 14-11-2023 | EMEA/H/C/005627 | 04-07-2023 | VALID | |
SOMATROGON | H01AC08 | IT | I | 28-04-2022 | EMEA/H/C/005633 | 14-02-2022 | VALID | |
LENACAPAVIR | J05AX31 | IT | I | 18-11-2022 | EMEA/H/C/005638 | 17-08-2022 | VALID | |
FARICIMAB | S01LA09 | IT | I | 18-11-2022 | EMEA/H/C/005642 | 15-09-2022 | VALID | |
SOTATERCEPT | C02KC06 | IT | POM | 01-08-2025 | EMEA/H/C/005647 | 22-08-2024 | VALID | |
SOTROVIMAB | J06BD05 | IT | I | 28-04-2022 | EMEA/H/C/005676 | 17-12-2021 | VALID | |
VAMOROLONE | H02AB18 | IT | I | 13-05-2024 | EMEA/H/C/005679 | 14-12-2023 | VALID | |
MELPHALAN FLUFENAMIDE | L01AA10 | IT | I | 18-11-2022 | EMEA/H/C/005681 | 17-08-2022 | VALID | |
LONCASTUXIMAB TESIRINE | L01FX22 | IT | I | 18-08-2023 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
BEVACIZUMAB | S01LA08 | IT | POM | 01-08-2025 | EMEA/H/C/005723 | 27-05-2024 | VALID | |
RIMEGEPANT | N02CD06 | IT | I | 18-11-2022 | EMEA/H/C/005725 | 25-04-2022 | VALID | |
COVID-19 VACCINES | J07BX03 | IT | I | 03-03-2021 | EMEA/H/C/005735 | 21-12-2020 | VALID | |
GLOFITAMAB | L01FX28 | IT | I | 14-11-2023 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
DEUCRAVACITINIB | L04AF07 | IT | I | 18-08-2023 | EMEA/H/C/005755 | 24-03-2023 | VALID | |
EXAGAMGLOGENE AUTOTEMCEL | B06AX05 | IT | I | 13-05-2024 | EMEA/H/C/005763 | 09-02-2024 | VALID | |
IPTACOPAN | L04AJ08 | IT | POM | 01-08-2025 | EMEA/H/C/005764 | 17-05-2024 | VALID | |
MOMELOTINIB | L01EJ04 | IT | I | 13-05-2024 | EMEA/H/C/005768 | 25-01-2024 | VALID | |
TRASTUZUMAB | L01XC03 | IT | I | 13-05-2024 | EMEA/H/C/005769 | 15-11-2023 | VALID | |
SUTIMLIMAB | L04AJ04 | IT | I | 18-08-2023 | EMEA/H/C/005776 | 15-11-2022 | VALID | |
SPARSENTAN | C09XX01 | IT | POM | 01-08-2025 | EMEA/H/C/005783 | 19-04-2024 | VALID | |
MARIBAVIR | J05AX10 | IT | I | 18-08-2023 | EMEA/H/C/005787 | 09-11-2022 | VALID | |
TIXAGEVIMAB AND CILGAVIMAB | J06BD03 | IT | I | 18-11-2022 | EMEA/H/C/005788 | 25-03-2022 | VALID | |
CASIRIVIMAB AND IMDEVIMAB | J06BD07 | IT | I | 28-04-2022 | EMEA/H/C/005814 | 12-11-2021 | VALID | |
INEBILIZUMAB | L04AG10 | IT | I | 18-11-2022 | EMEA/H/C/005818 | 25-04-2022 | VALID | |
ROZANOLIXIZUMAB | L04AG16 | IT | I | 13-05-2024 | EMEA/H/C/005824 | 05-01-2024 | VALID | |
RUXOLITINIB | D11AH09 | IT | I | 18-08-2023 | EMEA/H/C/005843 | 19-04-2023 | VALID | |
EFGARTIGIMOD ALFA | L04AA58 | IT | I | 18-11-2022 | EMEA/H/C/005849 | 10-08-2022 | VALID | |
FEZOLINETANT | G02CX06 | IT | I | 13-05-2024 | EMEA/H/C/005851 | 07-12-2023 | VALID | |
VUTRISIRAN | N07XX18 | IT | I | 18-11-2022 | EMEA/H/C/005852 | 15-09-2022 | VALID | |
REGDANVIMAB | J06BD06 | IT | I | 28-04-2022 | EMEA/H/C/005854 | 12-11-2021 | VALID | |
MARALIXIBAT CHLORIDE | A05AX04 | IT | I | 18-08-2023 | EMEA/H/C/005857 | 09-12-2022 | VALID | |
TALQUETAMAB | L01FX29 | IT | I | 14-11-2023 | EMEA/H/C/005864 | 21-08-2023 | VALID | |
ZOLBETUXIMAB | L01FX31 | IT | POM | 01-08-2025 | EMEA/H/C/005868 | 19-09-2024 | VALID | |
ATOGEPANT | N02CD07 | IT | I | 14-11-2023 | EMEA/H/C/005871 | 11-08-2023 | VALID | |
SPESOLIMAB | L04AC22 | IT | I | 18-08-2023 | EMEA/H/C/005874 | 09-12-2022 | VALID | |
LEBRIKIZUMAB | D11AH10 | IT | I | 13-05-2024 | EMEA/H/C/005894 | 16-11-2023 | VALID | |
REZAFUNGIN | J02AX08 | IT | I | 13-05-2024 | EMEA/H/C/005900 | 22-12-2023 | VALID | |
ELRANATAMAB | L01FX32 | IT | I | 13-05-2024 | EMEA/H/C/005908 | 07-12-2023 | VALID | |
QUIZARTINIB | L01EX11 | IT | I | 13-05-2024 | EMEA/H/C/005910 | 06-11-2023 | VALID | |
UBLITUXIMAB | L04AG14 | IT | I | 14-11-2023 | EMEA/H/C/005914 | 31-05-2023 | VALID | |
TISLELIZUMAB | L01FF09 | IT | I | 14-11-2023 | EMEA/H/C/005919 | 15-09-2023 | VALID |